Stoke Therapeutics (STOK) Shares Issued (2018 - 2026)
Stoke Therapeutics' quarterly Shares Issued came in at $465000.0 in Q1 2026, down 53.69% year-on-year from $1.0 million in Q1 2025, and down 93.88% quarter-over-quarter from $7.6 million in Q4 2025.
Stoke Therapeutics has reported Shares Issued for 9 years, with the latest figure at $465000.0 in Q1 2026.
- For the quarter ending Q1 2026, Shares Issued fell 53.69% year-over-year to $465000.0; the trailing twelve-month figure through Mar 2026 stood at $8.1 million (up 215.25% YoY), and the FY2025 full-year result was $8.6 million, up 399.59% from the prior year.
- Shares Issued for Q1 2026 stood at $465000.0, down from $7.6 million in the prior quarter.
- The five-year high for Shares Issued was $7.6 million in Q4 2025, with the low at -$556000.0 in Q3 2025.
- Average Shares Issued over 5 years is $700882.4, with a median of $168000.0 recorded in 2024.
- Year-over-year, Shares Issued surged 1666.67% in 2024 and slumped 500.0% in 2025.
- Tracing STOK's Shares Issued over 5 years: stood at $118000.0 in 2022, then surged by 59.32% to $188000.0 in 2023, then soared by 201.6% to $567000.0 in 2024, then jumped by 1240.56% to $7.6 million in 2025, then plunged by 93.88% to $465000.0 in 2026.
- The last three Shares Issued figures came in at $465000.0 (Q1 2026), $7.6 million (Q4 2025), and -$556000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 5.40 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 27.00 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 163.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.16 Mn |
| 10 | Stoke Therapeutics | 1.92 Bn | 1.92 Bn | - | 465,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 465,000.00 |
| Mar 31, 2026 | 465,000.00 |
| Dec 31, 2025 | 7.60 Mn |
| Dec 31, 2025 | 7.60 Mn |
| Sep 30, 2025 | -556,000.00 |
| Sep 30, 2025 | -556,000.00 |
| Jun 30, 2025 | 554,000.00 |
| Jun 30, 2025 | 554,000.00 |
| Mar 31, 2025 | 1.00 Mn |
| Mar 31, 2025 | 1.00 Mn |
| Dec 31, 2024 | 567,000.00 |
| Dec 31, 2024 | 567,000.00 |
| Sep 30, 2024 | 139,000.00 |
| Sep 30, 2024 | 139,000.00 |
| Jun 30, 2024 | 848,000.00 |
| Jun 30, 2024 | 848,000.00 |
| Mar 31, 2024 | 168,000.00 |
| Mar 31, 2024 | 168,000.00 |
| Dec 31, 2023 | 188,000.00 |
| Dec 31, 2023 | 188,000.00 |
| Sep 30, 2023 | 161,000.00 |
| Sep 30, 2023 | 161,000.00 |
| Jun 30, 2023 | 48,000.00 |
| Jun 30, 2023 | 48,000.00 |
| Mar 31, 2023 | 158,000.00 |
| Mar 31, 2023 | 158,000.00 |
| Dec 31, 2022 | 118,000.00 |
| Dec 31, 2022 | 118,000.00 |
| Sep 30, 2022 | 33,000.00 |
| Sep 30, 2022 | 33,000.00 |
| Jun 30, 2022 | 326,000.00 |
| Jun 30, 2022 | 326,000.00 |
| Mar 31, 2022 | 93,000.00 |
| Mar 31, 2022 | 93,000.00 |
| Dec 31, 2021 | 172,000.00 |
| Dec 31, 2021 | 172,000.00 |
| Sep 30, 2021 | 430,000.00 |
| Sep 30, 2021 | 430,000.00 |
| Mar 31, 2021 | 175,000.00 |
| Mar 31, 2021 | 175,000.00 |
| Sep 30, 2020 | -215,000.00 |
| Sep 30, 2020 | -215,000.00 |
| Jun 30, 2020 | 368,000.00 |
| Jun 30, 2020 | 368,000.00 |
| Mar 31, 2020 | 199,000.00 |
| Mar 31, 2020 | 199,000.00 |
| Dec 31, 2019 | 151.79 Mn |
| Dec 31, 2019 | 151.79 Mn |
| Sep 30, 2019 | -151.79 Mn |
| Sep 30, 2019 | -151.79 Mn |
| Jun 30, 2019 | 151.84 Mn |
| Jun 30, 2019 | 151.84 Mn |
| Mar 31, 2019 | 74,000.00 |
| Mar 31, 2019 | 74,000.00 |
| Dec 31, 2018 | 4,000.00 |
| Dec 31, 2018 | 4,000.00 |
| Sep 30, 2018 | 7,000.00 |
| Sep 30, 2018 | 7,000.00 |